TY - JOUR
KW - Buprenorphine access
KW - Comprehensive Addiction and Recovery Act
KW - Physicians
KW - Substance Abuse and Mental Health Services Administration
KW - Empirical Study
KW - Quantitative Study
KW - Human
KW - Adulthood (18 yrs & older)
KW - Allied Health Personnel
KW - Drug Abuse
KW - buprenorphine
KW - Mental Health Services
KW - Drug Laws
KW - US
KW - article
KW - 3383:Drug & Alcohol Rehabilitation
KW - Narcotic Antagonists
KW - United States
KW - Humans
KW - opioid-related disorders
KW - Opiate Substitution Treatment
AU - Dennis Lee
AU - Brendan Saloner
AU - Michael Barnett
A1 - 
AD - Department of Health Policy, Vanderbilt University, Nashville, TN, US dennis.lee.1@vanderbilt.edu; Department of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, US ; Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA, US ; Lee, Dennis,dennis.lee.1@vanderbilt.edu
BT - Psychiatric Services
C5 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
CP - 11
DO - 10.1176/appi.ps.202100122
IS - 11
JF - Psychiatric Services
LA - English
M1 - Journal Article
PY - 2021
SN - 1075-2730, 1075-2730
SP - 1358
EP - 1359
EP - 
T1 - Advanced practice providers and buprenorphine access in the United States after the Comprehensive Addiction and Recovery Act
T2 - Psychiatric Services
TI - Advanced practice providers and buprenorphine access in the United States after the Comprehensive Addiction and Recovery Act
U1 - Education & Workforce; Healthcare Policy; Opioids & Substance Use
U3 - 10.1176/appi.ps.202100122
VL - 72
VO - 1075-2730, 1075-2730
Y1 - 2021
Y2 - Nov 01
ER -